SEC Form 4 · accession 0001315406-18-000004
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Giovanni Magni
Officer — EVP, Chief Strategy Officer
Period of report
May 11, 2018
Accepted (ET)
May 11, 2018 · 8:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | May 11, 2018 | M | 3,500 | $88.00 | A | 12,751 | D | |
| Bio-Rad A Common Stock | May 11, 2018 | F | 1,918 | $284.98 | D | 10,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $88.00 | May 11, 2018 | M | 3,500 | D | — | Jun 11, 2018 | Bio-Rad A Common Stock | 3,500 | 0 | D |
Explanation of responses
- F1The option vested in five equal annual installments beginning on June 11, 2009.